We are live on
!
Find out more
1CM
1492 Capital Management Portfolio holdings
AUM
$263M
1-Year Est. Return
61.9%
This Fund
S&P 500
This Quarter
Est. Return
+16.57%
1 Year Est. Return
+61.9%
3 Year Est. Return
+187.15%
5 Year Est. Return
+242.53%
10 Year Est. Return
+2,731.07%
AUM
$154M
AUM Growth
+$13.6M
(+9.7%)
Cap. Flow
+$496K
Cap. Flow
% of AUM
0.32%
Top 10 Holdings %
Top 10 Hldgs %
34.87%
Holding
102
New
14
Increased
20
Reduced
50
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$1.26M |
| 2 |
Magnolia Oil & Gas
MGY
|
+$1.13M |
| 3 |
CRISPR Therapeutics
CRSP
|
+$930K |
| 4 |
BDSI
BioDelivery Sciences International, Inc.
BDSI
|
+$900K |
| 5 |
TSG
The Stars Group Inc.
TSG
|
+$882K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SKX
Skechers
SKX
|
+$3.11M |
| 2 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$2.13M |
| 3 |
IDTI
Integrated Device Technology I
IDTI
|
+$1.49M |
| 4 |
WIFI
Boingo Wireless, Inc.
WIFI
|
+$1.47M |
| 5 |
FCB
FCB Financial Holdings, Inc.
FCB
|
+$1.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.89% |
| 2 | Healthcare | 20.24% |
| 3 | Consumer Discretionary | 11.14% |
| 4 | Industrials | 9.34% |
| 5 | Financials | 8.4% |
Similar funds
KA
LCGC
DEA
EAN
PIP
VIG
SC
L
1492 Capital Management's Q3 2018 Portfolio in Review
As of Q3 2018, 1492 Capital Management held 102 positions worth $154M, up 9.7% from $140M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
1492 Capital Management's Q3 2018 filing shows 14 new, 20 increased, 50 reduced and 10 closed positions. Its largest new stake was Magnolia Oil & Gas: 86,399 shares worth $1.3M. The largest sale was Skechers, an estimated $3.11M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- 1492 Capital Management's largest Q3 2018 buy was Magnolia Oil & Gas: 86,399 shares worth $1.3M.
- 1492 Capital Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2018, an estimated $1.26M increase.
- 1492 Capital Management's biggest Q3 2018 reduction was Integrated Device Technology I, cutting an estimated $1.49M.
- 1492 Capital Management fully exited Skechers in Q3 2018, selling an estimated $3.11M.
- 1492 Capital Management's ten largest holdings make up 35% of its $154M portfolio in Q3 2018.
- 1492 Capital Management opened 14 new positions and closed 10 in Q3 2018.
- 1492 Capital Management's portfolio value rose 9.7% quarter-over-quarter to $154M.
Based on 1492 Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.